Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2005
11/23/2005CN1699415A Method for preparing insect protein with blood-fat reducing function
11/23/2005CN1699414A Functional peptide of milk agglutinin separated from MCF-7 and method for preparing same
11/23/2005CN1699413A Functional peptide of milk agglutinin and method for preparing same
11/23/2005CN1699412A Novel process for genetic engineering preparation of insulin and insulin analogs
11/23/2005CN1699411A Fungus conidium shape protein associated with pathogenicity and genes encoding same and use thereof
11/23/2005CN1699410A Apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders
11/23/2005CN1699406A Method for gel electrophoresis separation of serum lipoprotein and quantization detection thereof
11/23/2005CN1698894A Tumor necrosis factor antagonists and their use in endometriosis
11/23/2005CN1698881A Long lasting fusion peptide inhibitors of viral infection
11/23/2005CN1228450C Antigenic preparations
11/23/2005CN1228445C Bacterium and method for producing L-amino acid
11/23/2005CN1228345C Insoluble silk fibroin film and preparation of silk fibroin pipe
11/22/2005US6967268 Inbred maize line PHB6V
11/22/2005US6967267 Inbred maize line PH77P
11/22/2005US6967246 For stimulating release of tumor necrosis factor and or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
11/22/2005US6967245 Ucp5
11/22/2005US6967244 Neuronal nicotinic acetylcholine receptor compositions
11/22/2005US6967241 Process for protein extraction
11/22/2005US6967240 proteinaceous compound or functionally active derivative thereof having a binding site for a group of toxins derived from various cyanobacteria, to a method for its production, diagnostic kits, and affinty matrix for use in immunoaffinity column
11/22/2005US6967239 obtaining a starting factor VIII solution comprising factor VIII-von Willebrand factor complexes; and filtering in presence of calcium chloride ions through hydrophilic virus filter having a mean pore size of 13 to 17 nm
11/22/2005US6967238 Compounds and methods for modulating cell adhesion
11/22/2005US6967237 For use in stimulating growth hormone secretion
11/22/2005US6967100 Propagating islet of langerhans cells; obtain cells, culture in presence of bone morphogenic protein or modulator, monitor proliferation of cells
11/22/2005US6967092 Multi-functional chimeric hematopoietic receptor agonists
11/22/2005US6967091 Lowering circulating free fatty acid levels in an individual by administering to polypeptide and carrier
11/22/2005US6967090 Nucleic acid and protein sequences of bovine epidermal growth factor
11/22/2005US6967088 Soluble recombinant botulinum toxin proteins
11/22/2005US6967077 Methods and compositions for regulating T cell subsets by modulating transcription factor activity
11/22/2005US6967029 Method for increasing hematopoietic progenitor cells by stem cell factor
11/22/2005US6967019 Production of pancreatic islet cells and delivery of insulin
11/22/2005US6967018 Adiponectin gene therapy
11/22/2005US6966992 Purification of preferential particle from sample; obtain sample mixture, expose to chromatographic column, elute particle from column, recover particle
11/22/2005CA2267639C Synthetic hpv16 virus-like particles
11/22/2005CA2251558C Highly purified factor viii complex
11/22/2005CA2174081C Membrane protein polypeptide having function of supporting pre-b cell growth and gene therefor
11/22/2005CA2171531C Multiple branch peptide constructions for use against hiv
11/17/2005WO2005108995A2 Compositions, test kits and methods for detecting helicobacter pylori
11/17/2005WO2005108617A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005WO2005108611A2 Methods and compositions for the amplification of mutations in the diagnosis of cystic fibrosis
11/17/2005WO2005108587A1 Regulatory sequence for the expression of a gene in the axillary meristems of plants and applications thereof
11/17/2005WO2005108584A1 Recombinant chemokine-antigen vaccine
11/17/2005WO2005108580A1 Mutant pneumolysin proteins
11/17/2005WO2005108579A1 Polynucleotides for the detection of staphylococcus aureus
11/17/2005WO2005108578A1 Polynucleotides for the detection of escherichia coli
11/17/2005WO2005108576A1 Novel crustacean proline-rich peptides
11/17/2005WO2005108575A1 T-type calcium channel splice variant compositions and methods
11/17/2005WO2005108574A1 Gm1 PROMOTER AND USE THEREOF
11/17/2005WO2005108563A2 Peptidoglycan-hydrolyzing protein encoded by bacteriophage n4
11/17/2005WO2005108560A2 Synthesis and purification of west nile virus virus-like particles
11/17/2005WO2005108429A1 Novel soluble cd14 antigen
11/17/2005WO2005108428A2 Cd40 splice variants and their uses
11/17/2005WO2005108427A2 Method for producing soluble mhc proteins
11/17/2005WO2005108426A1 Peptide stabilization
11/17/2005WO2005108425A1 Il-23 p19 antigen array and uses thereof
11/17/2005WO2005108424A1 Crystal structure of the complex of hepatocyte growth factor bata chain with met receptor and methods of use
11/17/2005WO2005108423A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
11/17/2005WO2005108422A2 Ammonium/ammonia transporter
11/17/2005WO2005108421A1 Crystal structure of human proliferating cell nuclear antigen (pcna) and uses thereof
11/17/2005WO2005108420A1 Cancer associated antigens
11/17/2005WO2005108419A1 Mutant cholesterol-binding cytolysin proteins
11/17/2005WO2005108418A1 Compounds for specific viral target
11/17/2005WO2005108417A1 Polymeric primer for sugar peptide synthesis
11/17/2005WO2005108416A2 Myosin light chain kinase inhibitors and their use
11/17/2005WO2005108415A2 Membrane associated molecules
11/17/2005WO2005107796A2 Cellular permissivity factor for viruses, and uses thereof
11/17/2005WO2005107789A1 Use of delta pkc peptides for modulation of reactive oxigen species
11/17/2005WO2005107785A2 Human complement c3 derivates with cobra venom factor-like function
11/17/2005WO2005107776A1 METHOD OF ADMINISTERING PORCINE B-DOMAINLESS fVIII
11/17/2005WO2005107474A2 Oncolytic adenovirus armed with therapeutic genes
11/17/2005WO2005107396A2 Novel compositions and methods in cancer
11/17/2005WO2005107383A2 Secreted insecticidal protein and gene compositions from bacillus thuringiensis and uses therefor
11/17/2005WO2005107364A2 Polynucleotide, polypeptides, and diagnostic methods
11/17/2005WO2005107357A2 Analgesic peptides derived from the venom of crotalus durissus terrificuss snakes
11/17/2005WO2005092923A3 Cytonectin and gene inhibitors thereof
11/17/2005WO2005087809A3 Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion
11/17/2005WO2005082931B1 Novel phytochrome-interacting protein and a use thereof
11/17/2005WO2005080426A3 Protein ligands for nkg2d and ul16 receptors and uses thereof
11/17/2005WO2005066208A3 Method for production of recombinant growth hormone in form of hybrid protein
11/17/2005WO2005049648A3 Chimeric or fusion constructs of insulin-like growth factor binding proteins as chemotherapeutic agents
11/17/2005WO2005049644A3 Tool for the transfer and production of proteins using the pseudomonas type iii secretion system
11/17/2005WO2005047309A3 Prophylactic and therapeutic monoclonal antibodies
11/17/2005WO2005046714A3 Cytokine antagonist molecules
11/17/2005WO2005039643A3 In vivo gene therapy of parkinson's disease
11/17/2005WO2005014629A3 Protein from photobacterium damselae and use thereof
11/17/2005WO2005012606A3 Concentrated aqueous silk fibroin solution and use thereof
11/17/2005WO2004073736A8 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same
11/17/2005WO2004071422A3 Streptococcal serum opacity factors and fibronectin-binding proteins and peptides thereof for the treatment and detection of streptococcal infection
11/17/2005WO2004024087A3 Methods of diagnosing and treating hyperproliferative disorders
11/17/2005WO2003087321A8 Plant acyl-coa synthetases
11/17/2005WO2003084483A3 Methods for modulating angiogenesis via vegf
11/17/2005WO2003068941A3 Modulation of immune response by non-peptide binding stress response polypeptides
11/17/2005WO2003042399A8 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/17/2005WO2002096355A3 Compositions and methods for adipose abundant protein
11/17/2005WO2001072768A8 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
11/17/2005WO2001065911A9 Improved poloxamer and poloxamine compositions for nucleic acid delivery
11/17/2005WO1997049725A9 Modified factor viii
11/17/2005US20050257294 Generation of plants with improved drought tolerance
11/17/2005US20050257292 Ehd1gene promoting plant flowering, and utlization thereof
11/17/2005US20050257289 AP2 domain transcription factor ODP2 (ovule development protein 2) and methods of use
11/17/2005US20050257285 Compositions and methods for the treatment of Pierce's disease
1 ... 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 ... 2916